Sonova Holding (OTCMKTS:SONVY) Receives Consensus Rating of “Hold” from Analysts

Sonova Holding (OTCMKTS:SONVY – Get Free Report) has been given an average rating of “Hold” by the nine ratings firms that are covering the stock, MarketBeat Ratings reports. Two analysts have rated the stock with a sell rating, four have given a hold rating, one has issued a buy rating and two have issued a strong buy rating on the company.

SONVY has been the subject of several research analyst reports. BNP Paribas Exane raised shares of Sonova from a “strong sell” rating to a “strong-buy” rating in a research note on Tuesday, March 10th. Jefferies Financial Group lowered shares of Sonova from a “hold” rating to a “moderate sell” rating in a report on Wednesday, March 18th. Citigroup restated a “sell” rating on shares of Sonova in a report on Wednesday. Finally, Zacks Research upgraded shares of Sonova from a “strong sell” rating to a “hold” rating in a report on Monday, February 9th.

Get Sonova alerts:

Get Our Latest Stock Report on Sonova

Sonova Price Performance

Shares of OTCMKTS SONVY opened at $44.54 on Friday. The firm has a fifty day moving average price of $46.26 and a 200-day moving average price of $50.22. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.24 and a quick ratio of 0.91. Sonova has a 1 year low of $42.26 and a 1 year high of $68.76.

About Sonova

(Get Free Report)

Sonova AG (OTCMKTS:SONVY) is a Switzerland-based provider of hearing care solutions, headquartered in Stäfa. The company designs, develops, manufactures and distributes a range of audiological products and related services aimed at improving hearing and communication for people with hearing loss. Its portfolio spans behind-the-ear and in-the-ear hearing instruments, wireless accessories and software solutions that enable connectivity with consumer devices and audiological fittings.

Sonova markets its products under several well-known brands, including Phonak and Unitron for hearing aids, and it is also associated with Advanced Bionics for cochlear implant systems.

See Also

• Five stocks we like better than Sonova
• D-Wave Earnings Looked Weak, But Investors May Be Missing This
• Nebius Upside Expands as AI Feedback Loop Intensifies
• Insider Trades: Okta and Abbott See Buys, Micron Insiders Sell
• Plug Power Flips The Switch On Profitability

Receive News & Ratings for Sonova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sonova and related companies with MarketBeat.com's FREE daily email newsletter.